May 05 2015
European Pharma Summit (May 5-8, 2015, Berlin, Germany)
[Illinois] Center for Agricultural, Biomedical, and Pharmaceutical Nanotechnology (CABPN) 2012
08 Feb 2013 |
CABPN is a National Science Foundation (NSF) Industry/University Cooperative Research Center. Its mission is to conduct industry-relevant fundamental research, enhance graduate education and research, and to facilitate technology transfer to industry.-From the CABPN website
"Who Owns Truth?" - Biomedical Research in a Health Policy Context
30 Mar 2009 | | Contributor(s):: Samuel A. Richmond
This presentation examines a claim made by PhRMA on behalf of pharmaceutical manufacturing companies of America, and the response of the International Committee of Medical Journal Editors (ICMJE) questioning drug company publication policies and practices. Also considered are changes in law...
So What do Biologist, Biotechnologists & Pharmaceutical Scientist Want With an AFM/SPM Anyway?
out of 5 stars
11 Sep 2008 | | Contributor(s):: Kunal Bose
2008 BioNano Technology and Pharmaceuticals
06 Aug 2008 | | Contributor(s):: Pankaj Sharma, Nalam Madhusudhana Rao
The purpose of this symposium is to bring together top scientists from India and the United States to present their latest work and to discuss future international scientific collaborative partnerships. This one and a half day symposium will also feature a special second half day mini-symposium...
Micro-fabricated Biosensors for Cardiac Diagnostics
30 Jul 2008 | | Contributor(s):: V.Ramgopal Rao
In this talk the current status of an ongoing effort in the Electrical Engineering Department at IIT Bombay on the development of an integrated systems to provide point-of-care diagnostic support for cardiovascular diseases will be presented. The system under development monitors the molecular...
Self-association of peptides and proteins: Retrospect and prospects
30 Jul 2008 | | Contributor(s):: R. Nagaraj
The ability of peptides and proteins to form aggregates was known from the dawn of protein and peptide chemistry! It was often considered a nuisance and attention was directed towards disaggregating them to ensure dissolution particularly in aqueous solution. X-ray crystallography has indicated...
Nanohybrids as Sensors and Superstructures
30 Jul 2008 | | Contributor(s):: K. George Thomas
We have recently initiated a detailed research program on the design of nanoparticle conjugates of organic/inorganic molecules which enable the coupling of the intrinsic functionalities of molecular systems (binding, self-assembly, switching etc.) with the size and shape dependent optoelectronic...
Transforming Pharmaceutical Manufacturing in the 21st Century – Indiana as a Center for Biopharmaceutical Manufacturing
21 Jul 2008 | | Contributor(s):: Craig K. Svensson
The pharmaceutical industry is moving from a model of fully integrated pharmaceutical companies to fully networked pharmaceutical companies. In this latter model, major pharmaceutical companies are increasingly relying on partnerships for critical elements in the drug development process. This...
Quality by Design and Process Analytical Technology for Pharmaceutical Manufacturing in the 21st Century
21 Jul 2008 | | Contributor(s):: Stephen R. Byrn
PAT or Process Analytical Technology is an initiative and guidance from the U.S. FDA to encourage modernization of pharmaceutical manufacturing. In reality, PAT is a subset of the larger concept of Quality by Design which is the implementation of design concepts for pharmaceutical dosage forms...
Discovery Park at Purdue University: Engine for Academic and Commercial Growth
10 Jul 2008 | | Contributor(s):: Charles Buck, Pankaj Sharma
The Bindley Bioscience Center and Birck Nanotechnology Center at Discovery Park blend life sciences and engineering research to cultivate and support innovative, multi-investigator, interdisciplinary research teams. Discovery Park engages researchers in a broader perspective with applications of...
Pharmaceutical Manufacturing – Present and Future and What Should be the Role of India?
10 Jul 2008 | | Contributor(s):: Prabir K. Basu
Pharmaceutical manufacturing is at a crossroads. There is widespread realization among the regulators and the industry that the current state of high variability and “Quality by Inspection” is no longer adequate. While the industry still largely employs first generation quality management tools,...